Back to Journals » Pharmacogenomics and Personalized Medicine » Volume 19
Pharmacogenomics and Personalized Medicine
- View all (695)
- Volume 19, 2026 (7)
- Volume 18, 2025 (23)
- Volume 17, 2024 (44)
- Volume 16, 2023 (97)
- Volume 15, 2022 (82)
- Volume 14, 2021 (155)
- Volume 13, 2020 (72)
- Volume 12, 2019 (34)
- Volume 11, 2018 (24)
- Volume 10, 2017 (31)
- Volume 9, 2016 (14)
- Volume 8, 2015 (16)
- Volume 7, 2014 (37)
- Volume 6, 2013 (15)
- Volume 5, 2012 (12)
- Volume 4, 2011 (10)
- Volume 3, 2010 (11)
- Volume 2, 2009 (9)
- Volume 1, 2008 (2)
Archive: Volume 19, 2026
Population-Based Assessment of Phenoconversion Potential in Switzerland: A Claims Data Study of Key Drug-Metabolizing Enzymes and Transporters
Roth MM, Bencastro A, Meier CR, Huber CA, Meyer zu Schwabedissen HE, Allemann SS, Schneider C
Pharmacogenomics and Personalized Medicine 2026, 19:586384
Published Date: 20 May 2026
Massive Hepatocellular Carcinoma with Insufficient Future Liver Remnant Achieved Complete Response After Two-Stage Hepatectomy Combined with Hepatic Arterial Infusion Chemotherapy and Lenvatinib-sintilimab: A Case Report
Xu R, Zhang M, Zeng Z, Wei Y, Liao X, Yang C, Peng T, Su H
Pharmacogenomics and Personalized Medicine 2026, 19:578577
Published Date: 7 April 2026
Construction and Validation of Multi-Omics Predictive Models for Colorectal Cancer Using Machine-Learning Approaches
Lu Z, Li X, Liang Z, Zhang X, Tan Y, Kuang Y, Li K, Zhu X
Pharmacogenomics and Personalized Medicine 2026, 19:566928
Published Date: 2 April 2026
NAT2 Acetylation Phenotypes in India: A Narrative Review of Personalized TB Therapy
Khan N, Jonnalagadda M, Kumar R, Das A
Pharmacogenomics and Personalized Medicine 2026, 19:568037
Published Date: 10 March 2026
Bioinformatic Identification and Preliminary Validation of TP53, TGFB1, and NFE2L2 as Potential Ferroptosis-Related Regulators in Pancreatic Adenocarcinoma
Li S, Zhang C, Lv S, Zhang Z, Xu D, Xu T
Pharmacogenomics and Personalized Medicine 2026, 19:562602
Published Date: 17 February 2026
Post-Translational Modifications of Histones and Non-Histones in Liver Disease and Traditional Chinese Medicine Treatment: A Narrative Review
Xie Z, Deng Y, Zhang X, Chen J, Deng J, Fang Y, Ye X, Zhou Z
Pharmacogenomics and Personalized Medicine 2026, 19:555701
Published Date: 3 February 2026
Clinical Outcomes of Osimertinib Combined with Platinum-Based Chemotherapy in EGFR-Mutant Non-Small Cell Lung Cancer: A Retrospective Study
Han R, Yu X
Pharmacogenomics and Personalized Medicine 2026, 19:566952
Published Date: 3 February 2026